Press Release: ALX Oncology Appoints Allison Dillon as Chief Business Officer

ALX Oncology Appoints Allison Dillon as Chief Business Officer SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or "the Company") (Nasdaq: ALX

Dow JonesMay 7 21:00

ALX Oncology Holdings (NASDAQ:ALXO) Has Debt But No Earnings; Should You Worry?

Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems

Simply Wall StMay 4 20:39

ALX Oncology Board Reshuffles Following Director Resignations

TipRanksMay 3 04:26

ALX Oncology Announces Initiation Of Phase 2 Investigator-Sponsored Trial Of Neoadjuvant RadiationAand Evorpacept In Combination With Pembrolizumab In Patients With Untreated HPV-Mediated Oropharyngeal Cancer

ALX Oncology Announces Initiation Of Phase 2 Investigator-Sponsored Trial Of Neoadjuvant RadiationAand Evorpacept In Combination With Pembrolizumab In Patients With Untreated HPV-Mediated Oropharyngea

BenzingaApr 30 21:12

ALX Oncology Announces Two Evorpacept Abstracts Accepted for Poster Presentation at 2024 ASCO Annual Meeting

SOUTH SAN FRANCISCO, Calif., April 24, 2024 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology" or "the Company") (NASDAQ:ALXO), an immuno-oncology company developing therapies that block the CD47 immune

GlobeNewswireApr 24 22:00

ALX Oncology(ALXO.US) Officer Sells US$710.2K in Common Stock

$ALX Oncology(ALXO.US)$ Officer Pons Jaume sold 50,000 shares of common stock on Apr 16, 2024 at an average price of $14.2039 for a total value of $710.2K.Source: Announcement What is statement of cha

Futu NewsApr 19 05:31